Patents by Inventor Elizabeth Mambo

Elizabeth Mambo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140274791
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • Patent number: 8735074
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: May 27, 2014
    Assignee: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • Publication number: 20130029874
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as colorectal cancer, and using the profile in the diagnosis and/or prognosis of a patient for a condition, such as colorectal cancer and colorectal cancer recurrence or response to therapy.
    Type: Application
    Filed: October 5, 2012
    Publication date: January 31, 2013
    Inventors: Elizabeth Mambo, Timothy S. Davison, Paul A. LeBourgeois
  • Publication number: 20110053158
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 3, 2011
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth MAMBO, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • Publication number: 20090233297
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as colorectal cancer, and using the profile in the diagnosis and/or prognosis of a patient for a condition, such as colorectal cancer and colorectal cancer recurrence or response to therapy.
    Type: Application
    Filed: March 5, 2009
    Publication date: September 17, 2009
    Inventors: Elizabeth Mambo, Timothy S. Davison, Paul A. LeBourgeois